scispace - formally typeset
S

S. Anguiano-Igea

Researcher at University of Santiago de Compostela

Publications -  18
Citations -  546

S. Anguiano-Igea is an academic researcher from University of Santiago de Compostela. The author has contributed to research in topics: Self-healing hydrogels & Inclusion compound. The author has an hindex of 12, co-authored 18 publications receiving 518 citations.

Papers
More filters
Journal ArticleDOI

Chitosan and chondroitin microspheres for oral-administration controlled release of metoclopramide

TL;DR: The kinetics of drug release from chitosan microspheres were best fitted by models originally developed for systems in which release rate is largely governed by rate of diffusion through the matrix.
Journal ArticleDOI

In-vitro bioadhesion of carbopol hydrogels

TL;DR: In this paper, the adhesive capacity of hydrogels obtained from carbopol was evaluated using a tensile tester in which adhesion work was the main parameter and it was observed that when water was limited in the system there was an increase in adhesion due to the increase in elasticity caused by the formation of a complex between the polymer and the drug.
Journal ArticleDOI

A proton nuclear magnetic resonance study of the inclusion complex of naproxen with β-cyclodextrin

TL;DR: In this paper, a 1H-NMR study of the complex formed between naproxen (NAP) and β-cyclodextrin (β-CD) in aqueous medium is reported.
Journal ArticleDOI

Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting.

TL;DR: Spherical pellets containing 5% of triamcinolone acetonide were formed by extrusion/spheronization following formulation with microcrystalline cellulose (MCC) and/or a hydrophilic excipient to assess suitability for coating, with a view to colonic drug delivery.
Journal ArticleDOI

Oral bioavailability of naproxen-β-cyclodextrin inclusion compound

TL;DR: In this paper, an inclusion complex between naproxen and β-cyclodextrin was prepared by the freeze-drying method, and the bioavailability of the inclusion complex was evaluated using a new HPLC method for determining the drug and its glucuronide conjugate.